RPL13 and spondyloepimetaphyseal dysplasia: Although patient 2 has a milder phenotype, comparable to the recently reported SEMD patients with RPL13 mutations,(7) patients 1, 3, and 4 feature more severe skeletal changes and are likely to represent the severest end of the disease spectrum.